- Lobectomy is a standard treatment for stage I non–small cell lung cancer, but a significant proportion of patients are considered at high risk for complications, including mortality, after lobectomy and might not be candidates. Identifying who is at risk is important and in evolution. The objective of The American Association for Thoracic Surgery Clinical Practice Standards Committee expert panel was to review important considerations and factors in assessing who is at high risk among patients considered for lobectomy.
- It is estimated that more than 125 million people live with ischemic heart disease globally, and each year in the United States, 720,000 have a first myocardial infarction resulting in hospital admission or death.1,2 Approximately 35% of those who experience a coronary event in a given year die because of it, and each death is associated with an average of 16 years of life lost. Ischemic cardiomyopathy (ICM) is the single largest cause of heart failure (HF), although the underlying causes are often multifactorial and overlapping.
- Acute aortic dissection (AD) involves the ascending aorta in approximately two-thirds of patients.1,2 Chest pain is the most common feature, but clinical presentation can be varied, and algorithms have been developed to facilitate timely diagnosis.3,4 Nevertheless, delays in diagnosis comes at a severe cost to the patient.5 The complications of AD that involve the ascending aorta have been known for well over 60 years and include aortic rupture, cardiac tamponade, aortic regurgitation (AR), and organ malperfusion.
- Components of enhanced recovery programs (ERPs) for pediatric cardiac surgery across the perioperative period.